Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
References (38)
- et al.
Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats
Eur. J. Pharmacol.
(1981) - et al.
Excitatory amino acid receptors and synaptic plasticity
Trends Pharmacol. Sci.
(1990) - et al.
Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist
Brain Res.
(1990) - et al.
The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole
Eur. J. Pharmacol.
(1992) - et al.
NMDA receptor inhibition prevents tolerance to cocaine
Pharmacol. Biochem. Behav.
(1992) - et al.
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
Brain Res. Rev.
(1991) - et al.
Blockade of ‘reverse tolerance’ to cocaine and amphetamine by MK-801
Life Sci.
(1989) - et al.
Amphetamine sensitization and the excitatory amino acids
Brain Res.
(1990) - et al.
Effect of NMDA receptor antagonists on rapid tolerance to ethanol
Eur. J. Pharmacol.
(1993) MK-801 antagonizes methamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors
Brain Res.
(1990)
Antiparkinsonian drugs and in vitro excitotoxicity
Brain Res.
MK-801, a noncompetitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum
Neurosci. Lett.
Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine
Eur. J. Pharmacol.
Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum
Brain Res.
Effect of phencyclidine on spontaneous and (NKDA)-induced efflux of dopamine from superfused slices of rat striatum
Neuropharmacology
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
Brain Res. Rev.
Effects of chronic administration of phencyclidine on stereotyped and ataxic behaviors in the rat
Life Sci.
Comparison of the effects of MK-801 and phencyclidine on catecholamine uptate and NMDA-induced norepinephrine release
Eur. J. Pharmacol.
MK-901 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: An in vivo microdialysis study
Brain Res.
Cited by (102)
Mirtazapine exerts an anxiolytic-like effect through activation of the median raphe nucleus-dorsal hippocampal 5-HT pathway in contextual fear conditioning in rats
2016, Progress in Neuro-Psychopharmacology and Biological PsychiatryCitation Excerpt :Immediately after testing the expression of conditioned fear, rats were individually placed in a testing cage (38 × 33 × 17 cm) for the evaluation of spontaneous activity. Motor activity was automatically recorded, as described previously (Ohmori et al., 1994), using an apparatus with an infrared sensor that detects thermal radiation from animals over a period of 10 min (Supermex; Muromachi, Japan). Horizontal movement was digitized and used as the measure of general motor activity.
Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects
2016, Progress in Molecular Biology and Translational ScienceMemantine prevents "bipolar-like" behavior induced by chronic treatment with imipramine in rats
2015, European Journal of PharmacologyCitation Excerpt :Indeed, although the exact molecular mechanisms underlying the behavioral sensitization remain to be clarified (Ujike et al., 2002a; 2002b; Kawasaki et al., 2004; Landa et al., 2014), there is ample experimental evidence showing that the NMDA glutamate receptor plays an essential role in sensitization phenomena, especially in the sensitization (or reverse tolerance) to psychostimulants (Landa et al., 2014) that results in manic-like behaviors in animals and humans. Its stimulation is, in fact, necessary for the sensitization of amphetamine (Wolf et al., 1994; Ohmori et al., 1994; Vezina and Queen, 2000; Battisti et al., 2000; Pacchioni et al., 2002; Grönig et al., 2004), methylphenidate (Gaytan et al., 2000), cocaine (Li et al., 2000; Heusner and Palmiter, 2005; Rompré et al., 2006; Kim et al., 1996), apomorphine (Võikar et al., 1999; Acerbo et al., 2004) and other dopamine mimetics (Kalivas, 1995; Rockhold, 1998), nicotine (Kelsey et al., 2002), morphine (Jeziorski et al., 1994; Trujillo, 2002) and ethanol (Broadbent and Weitemier, 1999; Camarini et al., 2000; Kotlinska et al., 2006), as well as several types of stress such as, for instance, ‘restraint stress’ (Pacchioni et al., 2002) and ‘social defeat stress’ (Yap et al., 2005). Incidentally, it is worth recalling that the sensitization (also called reverse tolerance) to psychostimulants (amphetamine-cocaine) results in manic-like behaviors in animals and in manic-like syndromes in humans (indeed, the so called “ amphetamine psychosis” considered for a long time as “paranoid schizophrenia”, can be considered, in accordance with the more recent nosography, a manic episode with psychotic symptoms).
Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear
2015, European Journal of Pharmacology